Skip to main content
. Author manuscript; available in PMC: 2011 Sep 3.
Published in final edited form as: J Proteome Res. 2010 Sep 3;9(9):4620–4627. doi: 10.1021/pr1003449

Table 1.

Significance threshold α′ (×10−5) and effective number of tests (×103) based on Bon-ferroni correction (ENTB). 95% confidence intervals are given in parentheses. Bold figures are the proportion of Effective/Actual number of tests. Figures are based on 50,000 re-samples of the disease indicator under the null hypothesis.

Dataset Sample size
#Cases/controls
Overall error rate α =
1% 5%
Chinese population
High resolution
5 × 10−4 ppm
16,118 variables
836 spectra
50/50 α 0.48 (0.45;0.52) 13% 2.12 (2.03;2.19) 15%
ENTB 2.08 (1.92;2.24) 2.36 (2.28;2.46)

100/100 α 0.35 (0.33;0.39) 17% 1.64 (1.58;1.70) 19%
ENTB 2.82 (2.58;3.05) 3.06 (2.95;3.16)

200/200 α 0.25 (0.23;0.27) 25% 1.24 (1.19;1.31) 25%
ENTB 3.96 (3.69;4.26) 4.02 (3.83;4.19)

Chinese population
Medium resolution
10−3 ppm
7,100 variables
836 spectra
50/50 α 0.87 (0.82;0.94) 16% 3.81 (3.68;3.92) 18%
ENTB 1.14 (1.06;1.23) 1.31 (1.27;1.36)

100/100 α 0.66 (0.61;0.72) 21% 3.22 (3.09;3.36) 22%
ENTB 1.51 (1.40;1.64) 1.55 (1.49;1.62)

200/200 α 0.50 (0.46;0.54) 28% 2.48 (2.37;2.58) 28%
ENTB 2.00 (1.84;2.16) 2.02 (1.93;2.11)

US population
Medium resolution
10−3 ppm
7,100 variables
2164 spectra
50/50 α 1.04 (0.95;1.14) 14% 4.43 (4.28;4.59) 16%
ENTB 0.97 (0.88;1.05) 1.13 (1.09;1.17)

100/100 α 0.81 (0.73;0.86) 17% 3.61 (3.46;3.74) 20%
ENTB 1.24 (1.16;1.37) 1.39 (1.34;1.44)

200/200 α 0.65 (0.60;0.71) 22% 2.98 (2.84;3.07) 24%
ENTB 1.54 (1.41;1.68) 1.68 (1.63;1.75)

500/500 α 0.46 (0.44;0.51) 30% 2.41 (2.31;2.51) 29%
ENTB 2.15 (1.95;2.30) 2.07 (1.99;2.16)